Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia

By Aref S.   El-Sherbiny M.   Azmy E.   Goda T.   Selim T.   El-Refaie M.   Twafik E.  

Hematology, Vol. 13, Iss. 2, 2008-04 ,pp. : 95-100

Maney Publishing

Access to resources Recommend Favorite

Chromosomal abnormalities in acute myeloid leukaemias

By Mugneret F.   Callier P.   Favre-Audry B.  

Pathologie Biologie, Vol. 51, Iss. 6, 2003-08 ,pp. : 314-328

Elsevier

Access to resources Recommend Favorite

Prognostic significance of NPM1 mutations in acute myeloid leukemia: A meta-analysis

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 275-281

Spandidos Publications

Access to resources Recommend Favorite

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

By Greiner J.   Ringhoffer M.   Taniguchi M.   Schmitt A.   Kirchner D.   Krahn G.   Heilmann V.   Gschwend J.   Bergmann L.   Dohner H.   Schmitt M.  

Experimental Hematology, Vol. 30, Iss. 9, 2002-09 ,pp. : 1029-1035

Elsevier

Access to resources Recommend Favorite

Cytogenetic abnormalities in acute lymphoblastic leukemia

By Lafage-Pochitaloff M.   Charrin C.  

Pathologie Biologie, Vol. 51, Iss. 6, 2003-08 ,pp. : 329-336

Elsevier

Access to resources Recommend Favorite